B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis

Objective To investigate whether regulatory T cells (Treg) can control B cell function in rheumatoid arthritis (RA) and if not to explore the basis for this defect. Methods Suppression of B cell responses by Treg was analysed in vitro by flow cytometry and ELISA using peripheral blood mononuclear cells from 65 patients with RA and 41 sex-matched and aged-matched healthy volunteers. Blocking and agonistic antibodies were used to define the role of Fas-mediated apoptosis in B cell regulation. Results Treg failed to restrain B cell activation, proinflammatory cytokine and antibody production in the presence of responder T cells in RA patients. This lack of suppression was not only caused by impaired Treg function but was also due to B cell resistance to regulation. In healthy donors, control by Treg was associated with increased B cell death and relied upon Fas-mediated apoptosis. In contrast, RA B cells had reduced Fas expression compared with their healthy counterparts and were resistant to Fas-mediated apoptosis. Conclusions These studies demonstrate that Treg are unable to limit B cell responses in RA. This appears to be primarily due to B cell resistance to suppression, but Treg defects also contribute to this failure of regulation. Our data identify the Fas pathway as a novel target for Treg-mediated suppression of B cells and highlight a potential therapeutic approach to restore control of B cells by Treg in RA patients.

[1]  P. Petrow,et al.  The role of regulatory T cells in antigen-induced arthritis : aggravation of arthritis after depletion and amelioration after transfer of CD 4 + CD 25 + T cells , 2015 .

[2]  S. Gauld,et al.  Expansion of follicular helper T cells in the absence of Treg cells: Implications for loss of B‐cell anergy , 2012, European journal of immunology.

[3]  G. Koncz,et al.  The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells , 2012, Front. Immun..

[4]  C. Kurts,et al.  Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo , 2012, Proceedings of the National Academy of Sciences.

[5]  P. Krammer,et al.  Foxp3-Mediated Suppression of CD95L Expression Confers Resistance to Activation-Induced Cell Death in Regulatory T Cells , 2011, The Journal of Immunology.

[6]  M. Cho,et al.  Foxp3+ Regulatory T Cells Control Humoral Autoimmunity by Suppressing the Development of Long-Lived Plasma Cells , 2011, The Journal of Immunology.

[7]  I. Mérida,et al.  Diacylglycerol kinase α regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes , 2011, Cell Death and Differentiation.

[8]  Clare A. Notley,et al.  The yin and yang of regulatory T cells and inflammation in RA , 2010, Nature Reviews Rheumatology.

[9]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[10]  Jonathan H. Esensten,et al.  Regulatory T cells as therapeutic targets in rheumatoid arthritis , 2009, Nature Reviews Rheumatology.

[11]  A. La Cava,et al.  Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus1 , 2009, The Journal of Immunology.

[12]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[13]  A. Strasser,et al.  The many roles of FAS receptor signaling in the immune system. , 2009, Immunity.

[14]  P. Matarrese,et al.  Fas death receptor enhances endocytic membrane traffic converging into the Golgi region. , 2008, Molecular biology of the cell.

[15]  P. Opolon,et al.  Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells. , 2008, Immunity.

[16]  M. Ehrenstein,et al.  Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis , 2008, Proceedings of the National Academy of Sciences.

[17]  A. Hoerauf,et al.  Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR‐L interaction, IL‐10 and TGF‐β , 2008, European journal of immunology.

[18]  K. Rajewsky,et al.  Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. , 2008, Immunity.

[19]  P. Matarrese,et al.  Endosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells. , 2008, The Biochemical journal.

[20]  O. Janssen,et al.  Storage, expression and function of Fas ligand, the key death factor of immune cells. , 2008, Current medicinal chemistry.

[21]  T. Tedder,et al.  B‐lymphocyte contributions to human autoimmune disease , 2008, Immunological reviews.

[22]  Ching Li,et al.  Recent developments in the immunobiology of rheumatoid arthritis , 2008, Arthritis research & therapy.

[23]  M. Peter,et al.  The CD95 Receptor: Apoptosis Revisited , 2007, Cell.

[24]  M. Ehrenstein,et al.  Cells of the synovium in rheumatoid arthritis. B cells , 2007, Arthritis research & therapy.

[25]  G. Burmester,et al.  Cells of the synovium in rheumatoid arthritis , 2007 .

[26]  Claudia Mauri,et al.  Cells of the synovium in rheumatoid arthritis , 2007 .

[27]  G. Burmester,et al.  Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. , 2006, Autoimmunity reviews.

[28]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[29]  E. Shevach,et al.  Activated CD4+CD25+ T cells selectively kill B lymphocytes. , 2006, Blood.

[30]  F. Andris,et al.  CD4+CD25+ regulatory T cells control the magnitude ofT‐dependent humoral immune responses to exogenous antigens , 2006, European journal of immunology.

[31]  C. Hallas,et al.  The role of receptor internalization in CD95 signaling , 2006, The EMBO journal.

[32]  S. Peng.  Fas (CD95)-related apoptosis and rheumatoid arthritis. , 2006, Rheumatology.

[33]  A. Banham,et al.  Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[34]  P. Petrow,et al.  The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells , 2005, Arthritis research & therapy.

[35]  S. Peng.  Fas ( CD 95 )-related apoptosis and rheumatoid arthritis , 2005 .

[36]  B cells. , 2005, Critical care medicine.

[37]  P. Hillsamer,et al.  Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. , 2004, The Journal of clinical investigation.

[38]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[39]  Ehrenstein,et al.  Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy , 2004 .

[40]  L. Ricci-Vitiani,et al.  CD95 death‐inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells , 2004, European journal of immunology.

[41]  P. Emery,et al.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. , 2004, The New England journal of medicine.

[42]  Andreas Radbruch,et al.  CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function , 2004, The Journal of experimental medicine.

[43]  T. Mizuno,et al.  Fas-induced apoptosis in B cells , 2003, Apoptosis.

[44]  W. Janssens,et al.  CD4+CD25+ T Cells Lyse Antigen-Presenting B Cells by Fas-Fas Ligand Interaction in an Epitope-Specific Manner 1 , 2003, The Journal of Immunology.

[45]  R. Offringa,et al.  CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. , 2003, Arthritis and rheumatism.

[46]  W. El-Deiry,et al.  Cell surface Death Receptor signaling in normal and cancer cells. , 2003, Seminars in cancer biology.

[47]  F. Finkelman,et al.  The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. , 2002, Immunity.

[48]  Alicia Algeciras-Schimnich,et al.  Molecular Ordering of the Initial Signaling Events of CD95 , 2002, Molecular and Cellular Biology.

[49]  M. Shlomchik,et al.  From T to B and back again: positive feedback in systemic autoimmune disease , 2001, Nature Reviews Immunology.

[50]  W. Strober,et al.  Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.

[51]  M. Martínez-Lorenzo,et al.  Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.

[52]  G. Trinchieri,et al.  Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. , 1998, Journal of immunology.

[53]  H. Tsurui,et al.  Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.